Paper6830692
Central nervous system toxicity of interferon.
Rohatiner AZ and 5 others. Br J Cancer, 1983. Cited by 138 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Central nervous system toxicity of interferon. Papers, record 6830692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6830692
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Diseases | Major topic |
| Interferon Type I | Major topic |
| Drug Evaluation | |
| Electroencephalography | |
| Humans | |
| Leukemia |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 762,587 | Value of EEG in acute confusional states. | J Neurol Neurosurg Psychiatry | 1979 | https://conductscience.org/library/papers/762587 | PubMed |
| 2 | 431,720 | Interferon enhances the excitability of cultured neurones. | Nature | 1979 | https://conductscience.org/library/papers/431720 | PubMed |
| 3 | 6,157,064 | Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease. | Lancet | 1980 | https://conductscience.org/library/papers/6157064 | PubMed |
| 4 | 6,179,290 | p67K kinase in different tissues and plasma of control and interferon-treated mice. | Virology | 1982 | https://conductscience.org/library/papers/6179290 | PubMed |
| 5 | 7,172,412 | A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7172412 | PubMed |
| 6 | 6,891,329 | Conventional and spectral EEG analysis in children treated with cytotoxic agents. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6891329 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,584,262 | Aberrant Auditory Steady-State Response of Awake Mice Induced by Chronic Interferon-α Treatment. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33584262 | PubMed |
| 22,798,739 | Cognitive impairment in hepatitis C patients on antiviral therapy. | Gastroenterol Hepatol (N Y) | 2008 | https://conductscience.org/library/papers/22798739 | PubMed |
| 19,067,144 | Neuropsychiatric disorders related to interferon and interleukins treatment. | Metab Brain Dis | 2009 | https://conductscience.org/library/papers/19067144 | PubMed |
| 18,258,414 | IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. | Brain Behav Immun | 2008 | https://conductscience.org/library/papers/18258414 | PubMed |
| 16,216,160 | Neurobehavioral effects of interferon therapy. | Curr Psychiatry Rep | 2005 | https://conductscience.org/library/papers/16216160 | PubMed |
| 15,697,325 | Neuropsychiatric adverse effects of interferon-alpha: recognition and management. | CNS Drugs | 2005 | https://conductscience.org/library/papers/15697325 | PubMed |
| 10,903,965 | Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. | Br J Pharmacol | 2000 | https://conductscience.org/library/papers/10903965 | PubMed |
| 8,282,531 | Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment. | Ital J Neurol Sci | 1993 | https://conductscience.org/library/papers/8282531 | PubMed |
| 8,143,102 | Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer. | Support Care Cancer | 1993 | https://conductscience.org/library/papers/8143102 | PubMed |
| 7,681,371 | Interferon-alpha in malignant and viral diseases. A review. | Drugs | 1993 | https://conductscience.org/library/papers/7681371 | PubMed |
| 7,516,663 | Clinical toxicity of the interferons. | Drug Saf | 1994 | https://conductscience.org/library/papers/7516663 | PubMed |
| 7,505,042 | Interleukin-2 and interferon in renal cell carcinoma. | Med Oncol Tumor Pharmacother | 1993 | https://conductscience.org/library/papers/7505042 | PubMed |
| 6,403,186 | Neurological effects of recombinant human interferon. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6403186 | PubMed |
| 6,084,313 | Interferons, a group of multiple lymphokines. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6084313 | PubMed |
| 4,031,971 | Interferon-beta in patients with low-grade astrocytomas--a phase I study. | J Neurooncol | 1985 | https://conductscience.org/library/papers/4031971 | PubMed |
| 3,917,678 | Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3917678 | PubMed |
| 3,690,806 | A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3690806 | PubMed |
| 3,668,577 | Two cases of influenza B encephalitis. | J Neurol Neurosurg Psychiatry | 1987 | https://conductscience.org/library/papers/3668577 | PubMed |
| 3,548,648 | Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies. | Arch Toxicol | 1986 | https://conductscience.org/library/papers/3548648 | PubMed |
| 3,170,131 | Human leukocyte alpha interferon-induced transient neurotoxicity in children. | Invest New Drugs | 1988 | https://conductscience.org/library/papers/3170131 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6830692
GET https://conductscience.org/api/papers/v1/6830692/cited_by?page=2